The Current Ratio as of September 2024 (TTM) for Pacira BioSciences, Inc. (PCRX) is 6.82

According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.82. This represents a change of 20.48% compared to the average of 5.66 of the last 4 quarters.

Pacira BioSciences, Inc. (PCRX) Historical Current Ratio (quarterly & annually)

How has PCRX Current Ratio performed in the past?

The mean historical Current Ratio of Pacira BioSciences, Inc. over the last ten years is 4.01. The current 6.82 Current Ratio has changed 16.91% with respect to the historical average. Over the past ten years (40 quarters), PCRX's Current Ratio was at its highest in in the March 2017 quarter at 9.81. The Current Ratio was at its lowest in in the September 2014 quarter at 1.47.

Pacira BioSciences, Inc. (PCRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pacira BioSciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pacira BioSciences, Inc. (PCRX) Average Current Ratio

How has PCRX Current Ratio performed in the past?

The current Current Ratio of Pacira BioSciences, Inc. (PCRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pacira BioSciences, Inc. (PCRX) Current Ratio vs. Peers

How is PCRX’s Current Ratio compared to its peers?

Pacira BioSciences, Inc.’s Current Ratio is greater than Phibro Animal Health Corporation (2.94), greater than Dr. Reddy's Laboratories Limited (2.55), greater than Collegium Pharmaceutical, Inc. (1.11), greater than Silver Spike Investment Corp. (6.09), greater than Prestige Consumer Healthcare Inc. (3.23), greater than HUTCHMED (China) Limited (2.81), greater than Incannex Healthcare Limited (5.70), greater than Eagle Pharmaceuticals, Inc. (2.16), greater than ANI Pharmaceuticals, Inc. (3.97), greater than Deciphera Pharmaceuticals, Inc. (4.19), less than Intra-Cellular Therapies, Inc. (7.81), greater than Alkermes plc (2.99),

Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.